Bryce Point Capital LLC Makes New Investment in Progyny, Inc. (NASDAQ:PGNY)

Bryce Point Capital LLC acquired a new stake in shares of Progyny, Inc. (NASDAQ:PGNY) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 20,490 shares of the company’s stock, valued at approximately $353,000.

Several other hedge funds have also recently modified their holdings of PGNY. Vanguard Group Inc. increased its holdings in Progyny by 0.6% in the 4th quarter. Vanguard Group Inc. now owns 8,692,132 shares of the company’s stock valued at $149,939,000 after acquiring an additional 48,271 shares during the last quarter. Pacer Advisors Inc. grew its position in Progyny by 47.5% in the fourth quarter. Pacer Advisors Inc. now owns 3,676,200 shares of the company’s stock worth $63,414,000 after acquiring an additional 1,183,558 shares in the last quarter. State Street Corp boosted its holdings in shares of Progyny by 4.5% in the 3rd quarter. State Street Corp now owns 3,113,654 shares of the company’s stock worth $52,185,000 after purchasing an additional 134,861 shares during the period. River Road Asset Management LLC bought a new position in Progyny during the fourth quarter valued at $25,529,000. Finally, Fort Washington Investment Advisors Inc. OH grew its holdings in Progyny by 90.1% during the 4th quarter. Fort Washington Investment Advisors Inc. OH now owns 1,467,780 shares of the company’s stock valued at $25,319,000 after purchasing an additional 695,740 shares during the last quarter. Hedge funds and other institutional investors own 94.93% of the company’s stock.

Progyny Stock Down 2.4 %

Shares of Progyny stock opened at $22.60 on Friday. The firm has a market capitalization of $1.93 billion, a P/E ratio of 38.97, a PEG ratio of 2.39 and a beta of 1.33. Progyny, Inc. has a 52 week low of $13.39 and a 52 week high of $36.36. The company has a 50 day moving average price of $22.19 and a 200 day moving average price of $18.54.

Analyst Upgrades and Downgrades

A number of research analysts have recently commented on PGNY shares. Canaccord Genuity Group upped their price target on shares of Progyny from $17.00 to $23.00 and gave the stock a “hold” rating in a report on Friday, February 28th. Bank of America boosted their price objective on shares of Progyny from $21.00 to $25.00 and gave the stock a “buy” rating in a research note on Tuesday, February 11th. JPMorgan Chase & Co. increased their target price on Progyny from $17.00 to $23.00 and gave the company a “neutral” rating in a research report on Tuesday, January 28th. Finally, BTIG Research raised Progyny from a “neutral” rating to a “buy” rating and set a $28.00 price target for the company in a research report on Monday, March 31st. Eight research analysts have rated the stock with a hold rating and five have issued a buy rating to the company. Based on data from MarketBeat, Progyny has an average rating of “Hold” and an average target price of $23.64.

About Progyny

Progyny, Inc, a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists.